Inhibition of the RAF1 gene by MiR-7-5p is associated with inhibition of vascular endothelial cell proliferation because Raf1 activates growth factor signaling downstream of the epidermal growth factor receptor (EGFR), a major drug target in GBM [105]. This evidence concerns the gene RAF1 and glioblastoma.